Orthologic Corp.
1275 West Washington Street
Tempe,
AZ 85281
United States - Map
Phone: 602-286-5520
Fax: 602-286-5524
Web Site: http://www.orthologic.com
| OrthoLogic Corp., doing business as Capstone Therapeutics, focuses on the development and commercialization of therapeutic peptides and other molecules for patients with under-served conditions. The companys product includes Chrysalin, or TP508, a 23-amino acid synthetic peptide, which is under pre-clinical testing for vascular applications, such as acute myocardial infarction and chronic myocardial ischemia. It also offers AZX100, a synthetic 24-amino acid peptide to relax smooth muscle, which modulates blood pressure and the function of blood vessels, airways, sphincters, the gastrointestinal tract, and the genitourinary tract. AZX100 is also evaluated for medical and commercial applications, such as treatment of pulmonary disease, prevention of hypertrophic and keloid scarring, and intimal hyperplasia. The company was formerly known as IatroMed, Inc. and changed its name to OrthoLogic Corp. in July 1991. OrthoLogic Corp. was founded in 1987 and is based in Tempe, Arizona. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. John M. Holliman III,
Exec. Chairman, Chief Exec. Officer and Member of Exec. Committee |
$
236.00K | N/A | Dr. Randolph C. Steer Ph.D., M.D., 60
Pres and Chief Operating Officer |
$
414.00K | N/A | Mr. Leslie M. Taeger , 59
Chief Financial Officer, Principal Accounting Officer and Sr. VP |
$
324.00K | N/A | Dr. William M. Wardell M.D., Ph.D., 71
Head of Clinical & Regulatory Review Board, Director and Member of Corp. Governance & Nominating Committee |
$
36.00K | N/A | Mr. Dana B. Shinbaum , 47
VP of Bus. Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.14% Nasdaq 
0.03 (4.24%) 
Profile
